These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22401656)

  • 21. Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome.
    Du Y; Li X; Liu B
    Life Sci; 2014 Mar; 99(1-2):1-6. PubMed ID: 24140889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Tumlin JA; Costanzo MR; Chawla LS; Herzog CA; Kellum JA; McCullough PA; Ronco C
    Contrib Nephrol; 2013; 182():158-73. PubMed ID: 23689661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors for cardiovascular system damage in chronic kidney disease].
    Kutyrina IM; Rudenko TE; Savel'eva SA; Shvetsov MIu; Vasil'eva MP
    Ter Arkh; 2013; 85(9):69-76. PubMed ID: 24261233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorenal syndrome.
    Ronco C; Di Lullo L
    Heart Fail Clin; 2014 Apr; 10(2):251-80. PubMed ID: 24656104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiorenal syndrome: currents views of relationships between renal and cardiovascular diseases].
    Vesnina ZhV; Arsen'eva IuA
    Klin Med (Mosk); 2012; 90(7):8-13. PubMed ID: 23019967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Of heart and kidney: a complicated love story.
    Gaita D; Mihaescu A; Schiller A
    Eur J Prev Cardiol; 2014 Jul; 21(7):840-6. PubMed ID: 23012690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial Dysfunction in the Cardio-Renal Axis.
    Mendez-Barbero N; Oller J; Sanz AB; Ramos AM; Ortiz A; Ruiz-Ortega M; Rayego-Mateos S
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac Hypertrophy and Cardiac Cell Death in Chronic Kidney Disease.
    Rofe MT; Levi R; Hertzberg-Bigelman E; Goryainov P; Barashi R; Ben-Shoshan J; Keren G; Entin-Meer M
    Isr Med Assoc J; 2015 Dec; 17(12):744-9. PubMed ID: 26897975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal biomarkers for the prediction of cardiovascular disease.
    Joshi S; Viljoen A
    Curr Opin Cardiol; 2015 Jul; 30(4):454-60. PubMed ID: 26049396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum].
    Mukhin NA; Glybochko PV; Svistunov AA; Fomin VV; Kiyakbaev GG
    Ter Arkh; 2016; 88(6):4-8. PubMed ID: 27489904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
    Fu Q; Cao L; Li H; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathophysiology and diagnosis of cardio-renal syndrome: actual picture and future prospectives].
    Di Lullo L; Floccari F; De Pascalis A; Marinelli A; Barbera V; Santoboni A; Malaguti M; Balducci A; Russo D; Rivera R; Gorini A; Ronco C
    G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-renal-anemia syndrome: a report of three cases.
    Okafor UH; Unuigbe EI
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):562-8. PubMed ID: 22569446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease.
    Li X; Yang XC; Sun QM; Chen XD; Li YC
    Chin Med J (Engl); 2013 Mar; 126(5):823-7. PubMed ID: 23489784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins.
    Lekawanvijit S; Kompa AR; Wang BH; Kelly DJ; Krum H
    Circ Res; 2012 Nov; 111(11):1470-83. PubMed ID: 23139286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Omics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes.
    Virzì GM; Clementi A; Battaglia GG; Ronco C
    Cardiorenal Med; 2019; 9(4):201-211. PubMed ID: 30939477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease.
    Peev V; Nayer A; Contreras G
    Curr Opin Lipidol; 2014 Feb; 25(1):54-60. PubMed ID: 24345987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
    Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
    Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.